1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.
- Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
- 2013
- Amelioration of Experimental Autoimmune Encephalomyelitis by the Quinoline-3-Carboxamide Paquinimod (ABR-215757): Reduced Priming of Proinflammatory Effector CD4(+) T Cells.
- The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity.
- 2003
- Superantigen-Induced Regulatory T Cells Display Different Suppressive Functions in the Presence or Absence of Natural CD4(+)CD25(+) Regulatory T Cells In Vivo.
- 2000
-
Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells.
Li, Suling ; Chen, Shangwu ; Xu, X. ; Sundstedt, Anette LU ; Paulsson, Kajsa LU
;
andersson, Per
;
Karlsson, Stefan
LU
;
Sjögren, Hans Olov
LU
and
Wang, Ping
(2000)
In Journal of Experimental Medicine
191(6).
p.985-994
Mark
- 1998
- Regulatory mechanisms controlling T cell activity